Reduction of Disease Activity in Patient with Relapsing-Remitting Multiple Sclerosis after Switching to Teriflunomide from Interferon Beta
Kyu Sik Shin, Jae Gun Park, Min Su Park
J Korean Neurol Assoc. 2016;34(1):77-79. Published online 2016 Feb 1 DOI: https://doi.org/10.17340/jkna.2016.1.17
Citations to this article as recorded by 
Real-world effectiveness and safety profile of teriflunomide in the management of multiple sclerosis in the Gulf Cooperation Council countries: An expert consensus narrative review
Raed Alroughani, Jihad Inshasi, Mona Al Khawajah, Samar Farouk Ahmed, Yaser Al Malik, Jaber Alkhabouri, Ahmed Shatila, Salman Aljarallah, Edward J Cupler, Shireen Al Qureshi, Mona Thakre, Heba Elhasin, Aly Ezzat, Sherif Roushdy
Multiple Sclerosis Journal - Experimental, Transla.2022; 8(1): 205521732210771. CrossRef